Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
cancer discovery
Apr 15, 2024, 13:18 | Blog
Maria Babak: Babak Monthly in April - Transforming Cancer Care 
Jemma Arakelyan, Medical Oncologist and CEO at the Institute of Cancer and Crisis, shared a post…
Apr 14, 2024, 07:35 | Drugs
Charles Swanton: What is the role of the TME in lung cancer evolution?
Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…
Apr 14, 2024, 06:54 | Opinion
Kimryn Rathmell: The National Cancer Plan is meant to drive innovation in cancer research
Kimryn Rathmell, Director of the National Cancer Institute, shared on X/Twitter: "The National Cancer Plan…
Apr 11, 2024, 16:08 | Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 11, 2024, 15:23 | Drugs
Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 06:46 | Opinion
Maria Natalia Gandur Quiroga: The Hallmarks of Precancer
Maria Natalia Gandur Quiroga shared a post on X: "The Hallmarks of Precancer. AACR Journals,…
Apr 10, 2024, 08:41 | Drugs
Piotr Wysocki: CAR-T cells targeting CD70 for renal cell cancer – promising results of a phase I COBALT-RCC study (AACR2024)
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 10, 2024, 05:50 | Blog
The Innovation Oncology - Loss-of-Function properties of mutant TP53 are critical for a broad range of cancer cells
The Innovation Oncology shared on X/Twitter: ''Loss-of-Function, but Not Gain-of-Function properties of mutant TP53 are…
Apr 9, 2024, 13:33 | Blog
Biagio Ricciuti: If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''If you are at…
Apr 9, 2024, 05:08 | Blog
Johanna Joyce: Embracing cancer complexity: Hallmarks of systemic disease
Johanna Joyce shared a post on LinkedIn: "'Embracing cancer complexity: Hallmarks of systemic disease' It was…
All: 742 Posts: 241 - 250
Special Coverage